The Effect of Neostigmine and Sugammadex on the Optic Nerve Sheath Diameter

Clinical trial NCT07666984 · RECRUITING

Trial details

NCT number: NCT07666984
Sponsor: Cukurova University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade Reversal Agent

Start date: 2026-06-04
Primary completion: 2026-07-10
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.